Trans-Ancestral Studies Fine Map the SLE-Susceptibility Locus

English version České info

We previously established an 80 kb haplotype upstream of TNFSF4 as a susceptibility locus in the autoimmune disease SLE. SLE-associated alleles at this locus are associated with inflammatory disorders, including atherosclerosis and ischaemic stroke. In Europeans, the TNFSF4 causal variants have remained elusive due to strong linkage disequilibrium exhibited by alleles spanning the region. Using a trans-ancestral approach to fine-map the locus, utilising 17,900 SLE and control subjects including Amerindian/Hispanics (1348 cases, 717 controls), African-Americans (AA) (1529, 2048) and better powered cohorts of Europeans and East Asians, we find strong association of risk alleles in all ethnicities; the AA association replicates in African-American Gullah (152,122). The best evidence of association comes from two adjacent markers: rs2205960-T (P = 1.71×10⁻³⁴, OR = 1.43[1.26–1.60]) and rs1234317-T (P = 1.16×10⁻²⁸, OR = 1.38[1.24–1.54]). Inference of fine-scale recombination rates for all populations tested finds the 80 kb risk and non-risk haplotypes in all except African-Americans. In this population the decay of recombination equates to an 11 kb risk haplotype, anchored in the 5′ region proximal to TNFSF4 and tagged by rs2205960-T after 1000 Genomes phase 1 (v3) imputation. Conditional regression analyses delineate the 5′ risk signal to rs2205960-T and the independent non-risk signal to rs1234314-C. Our case-only and SLE-control cohorts demonstrate robust association of rs2205960-T with autoantibody production. The rs2205960-T is predicted to form part of a decameric motif which binds NF-κBp65 with increased affinity compared to rs2205960-G. ChIP-seq data also indicate NF-κB interaction with the DNA sequence at this position in LCL cells. Our research suggests association of rs2205960-T with SLE across multiple groups and an independent non-risk signal at rs1234314-C. rs2205960-T is associated with autoantibody production and lymphopenia. Our data confirm a global signal at TNFSF4 and a role for the expressed product at multiple stages of lymphocyte dysregulation during SLE pathogenesis. We confirm the validity of trans-ancestral mapping in a complex trait.

Vyšlo v časopise: Trans-Ancestral Studies Fine Map the SLE-Susceptibility Locus. PLoS Genet 9(7): e32767. doi:10.1371/journal.pgen.1003554
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pgen.1003554

Souhrn

Zdroje

1. CroftM (2010) Control of immunity by the TNFR-related molecule OX40 (CD134). Annu Rev Immunol 28: 57–78.

2. SoT, ChoiH, CroftM (2011) OX40 complexes with phosphoinositide 3-kinase and protein kinase B (PKB) to augment TCR-dependent PKB signalling. J Immunol 186: 3547–55.

3. GriG, PiconeseS, FrossiB, ManfroiV, MerluzziS, et al. (2008) CD4+CD25+ regulatory T cells suppress mast cell degranulation and allergic responses through OX40-OX40L interaction. Immunity 29: 771–781.

4. Cunninghame GrahamDS, GrahamRR, MankuH, WongAK, WhittakerJC, et al. (2008) Polymorphism at the TNF Superfamily Gene OX40L Confers Susceptibility to Systemic Lupus Erythematosus. Nat Genet 40: 83–9.

5. ZainiJ, AndariniS, TaharaM, SaijoY, IshiiN, et al. (2007) OX40 ligand expressed by DCs costimulates NKT and CD4+ Th cell antitumor immunity in mice. J Clin Invest 117: 3330–3338.

6. SeshasayeeD, LeeWP, ZhouM, ShuJ, SutoE, et al. (2007) In vivo blockade of OX40 ligand inhibits thymic stromal lymphopoietin driven atopic inflammation. J Clin Invest 117: 3868–3878.

7. ItoT, WangYH, DuramadO, HanabuchiS, PerngOA, et al. (2006) OX40 ligand shuts down IL-10-producing regulatory T cells. Proc Natl Acad Sci U S A 103: 13138–13143.

8. CompaanDM, HymowitzSG (2006) The crystal structure of the costimulatory OX40-OX40L complex. Structure 14: 1321–1330.

9. NoharaC, AkibaH, NakajimaA, InoueA, KohCS, et al. (2001) Amelioration of experimental autoimmune encephalomyelitis with anti-OX40 ligand monoclonal antibody: a critical role for OX40 ligand in migration, but not development, of pathogenic T cells. J Immunol 166: 2108–2115.

10. RhodesB, VyseTJ (2008) The genetics of SLE: an update in the light of genome-wide association studies. Rheumatology. (Oxford) 47: 1603–1611.

11. HomG, GrahamRR, ModrekB, TaylorKE, OrtmannW, et al. (2008) Association of systemic lupus erythematosus with C8orf13-BLK and ITGAM-ITGAX. N Engl J Med 358: 900–909.

12. GrahamRR, CotsapasC, DaviesL, HackettR, LessardCJ, et al. (2008) Genetic variants near TNFAIP3 on 6q23 are associated with systemic lupus erythematosus. Nat Genet 40: 1059–61.

13. HarleyJB, Alarcon-RiquelmeME, CriswellLA, JacobCO, KimberlyRP, et al. (2008) Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci. Nat Genet 40: 204–210.

14. HanJW, ZhengHF, CuiY, SunLD, YeDQ, et al. (2009) Genome-wide association study in a Chinese Han population identifies nine new susceptibility loci for systemic lupus erythematosus. Nat Genet 41: 1234–1237.

15. YangW, ShenN, YeDQ, LiuQ, ZhangY, et al. (2010) Genome-wide association study in Asian populations identifies variants in ETS1 and WDFY4 associated with systemic lupus erythematosus. PLOS Genet 6: e1000841.

16. BrycK, VelezC, KarafetT, Moreno-EstradaA, ReynoldsA, et al. (2010) Colloquium paper: genome-wide patterns of population structure and admixture among Hispanic/Latino populations. Proc Natl Acad Sci U S A 107: 8954–8961.

17. NordmarkG, KristjansdottirG, TheanderE, AppelS, ErikssonP, et al. (2011) Association of EBF1, FAM167A (C8orf13)-BLK and TNFSF4 gene variants with primary Sjögren's syndrome. Genes Immun 12: 100–9.

18. WangX, RiaM, KelmensonPM, ErikssonP, HigginsDC, et al. (2005) Positional identification of TNFSF4, encoding OX40 ligand, as a gene that influences atherosclerosis susceptibility. Nat Genet 37: 365–72.

19. RiaM, LagercrantzJ, SamnegårdA, BoquistS, HamstenA, et al. (2011) Common polymorphism in the promoter region of the TNFSF4 gene is associated with lower allele-specific expression and risk of myocardial infarction. PLOSOne 18: e17652.

20. FosterMW, SharpRR (2004) Beyond race: towards a whole-genome perspective on human populations and genetic variation. Nat Rev Genet 5: 790–796.

21. MolinaJF, MolinaJ, GarciaC, GharaviAE, WilsonWA (1997) Ethnic differences in the clinical expression of systemic lupus erythematosus: a comparative study between African-Americans and Latin Americans. Lupus 6: 63–67.

22. FernandezM, AlarconGS, Calvo-AlenJ, AndradeR, McGwinGJr, et al. (2007) A multiethnic, multicenter cohort of patients with systemic lupus erythematosus (SLE) as a model for the study of ethnic disparities in SLE. Arthritis Rheum 57: 576–584.

23. WinklerCA, NelsonGW, SmithMW (2010) Admixture mapping comes of age. Annu Rev Genomics Hum Genet 11: 65–89.

24. SebastianiP, LazarusR, WeissST, KunkelLM, KohaneIS (2003) Minimal haplotype tagging. Proc Natl Acad Sci U S A 100: 9900–9905.

25. DalyMJ, RiouxJD, SchaffnerSF, HudsonTJ, LanderES (2001) High-resolution haplotype structure in the human genome. Nat Genet 29: 229–232.

26. PriceAL, PattersonN, YuF, CoxDR, WaliszewskaA, et al. (2007) A genomewide admixture map for Latino populations. Am J Hum Genet 80: 1024–1036.

27. KamenDL, BarronM, ParkerTM, ShaftmanSR, BrunerGR, et al. (2008) Autoantibody prevalence and lupus disease characteristics in a unique African American population. Arthritis Rheum 58: 1237–47.

28. NamjouB, SestakAL, ArmstrongDL, ZidovetzkiR, KellyJA, et al. (2009) High-density genotyping of STAT4 reveals multiple haplotypic associations with systemic lupus erythematosus in different racial groups. Arthritis Rheum 60: 1085–1095.

29. HalderI, ShriverM, ThomasM, FernandezJR, FrudakisT (2008) A panel of ancestry informative markers for estimating individual biogeographical ancestry and admixture from four continents: utility and applications. Hum Mutat 29: 648–658.

30. The 1000 Genomes Project Consortium (2010) A map of human genome variation from population-scale sequencing. Nature 467: 1061–73.

31. The International HapMap Consortium (2003) The International HapMap Project. Nature 426: 789–796.

32. AutonA, McVeanG (2007) Recombination rate estimation in the presence of hotspots. Genome Res 17: 1219–1227.

33. TanEM, CohenAS, FriesJF, MasiAT, McShaneDJ, et al. (1997) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25:1271–7. and Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus [letter]. Arthritis Rheu 40: 1725.

34. Thierry-MiegD, Thierry-MiegJ (2006) AceView: a comprehensive cDNA-supported gene and transcripts annotation. Genome Biol 7 Suppl 1: S12–S14.

35. GrundbergE, SmallKS, HedmanÅK, NicaAC, BuilA, et al. (2012) Mapping cis- and trans-regulatory effects across multiple tissues in twins. Nat Genet 44 (10) 1084–9.

36. Portales-CasamarE, ThongjueaS, KwonAT, ArenillasD, ZhaoX, et al. (2010) JASPAR 2010: the greatly expanded open-access database of transcription factor binding profiles. Nucleic Acids Res 38: D105–10.

37. ENCODE Project Consortium (2012) BernsteinBE, BirneyE, DunhamI, GreenED, et al. (2012) An integrated encyclopedia of DNA elements in the human genome. Nature 489: 57–74.

38. IkushimaS, InukaiT, InabaT, NimerSD, ClevelandJL, et al. (1997) Pivotal role for the NFIL3/E4BP4 transcription factor in interleukin 3-mediated survival of pro-B lymphocytes. Proc Natl Acad Sci U S A 94: 2609–2614.

39. Delgado-VegaAM, AbelsonAK, SanchezE, WitteT, D'AlfonsoS, et al. (2009) Replication of the TNFSF4 (OX40L) promoter region association with systemic lupus erythematosus. Genes Immun 10: 248–253.

40. SanchezE, WebbRD, RasmussenA, KellyJA, RibaL, et al. (2010) Genetically determined Amerindian ancestry correlates with increased frequency of risk alleles for systemic lupus erythematosus. Arthritis Rheum 12: 3722–9.